Saffron does appear to help with depression, and the evidence is stronger than for most supplements. Multiple clinical trials have found that 30 mg per day of saffron extract reduces depressive symptoms significantly more than a placebo, and several head-to-head trials show it performing on par with common prescription antidepressants for mild to moderate depression.
That said, the research has limits. Most trials have been small, and saffron has not been tested against the full range of depression severity. Here’s what the science actually shows, what dose works, and what to realistically expect.
What the Clinical Trials Found
A meta-analysis pooling data from randomized controlled trials found a large effect size (1.62) for saffron versus placebo in reducing depressive symptoms. To put that in perspective, an effect size above 0.8 is considered “large” in clinical research, so 1.62 is well beyond that threshold. In one trial, participants taking 30 mg of saffron extract daily scored meaningfully better on a standard depression rating scale than those on placebo by the end of six weeks.
The largest trial to date, involving 202 adults with subclinical depressive symptoms, tested a standardized saffron extract (affron, 28 mg daily) over 12 weeks. In that study, 72.3% of participants in the saffron group achieved a clinically meaningful reduction in depression scores, compared to 54.3% in the placebo group. A subset of participants with sleep problems also saw improvements in sleep disturbances. No serious adverse reactions were reported.
It’s worth noting that placebo responses in depression trials tend to be large on their own. The 54.3% improvement rate in the placebo group of that trial is a good example. Saffron clearly outperformed placebo, but the gap narrows when placebo effects are strong.
How It Compares to Antidepressants
Several six-week trials have directly compared saffron to prescription antidepressants, and the results are surprisingly close. A systematic review of eight studies found no statistically significant difference between saffron (30 mg/day) and fluoxetine (Prozac) at either 20 mg or 40 mg doses. The standardized mean difference between the two was just 0.11, essentially negligible.
Other trials have matched saffron against imipramine (100 mg/day), sertraline (Zoloft, 50 mg/day), and citalopram (Celexa, 40 mg/day), all with similar findings: saffron performed comparably over six weeks. One trial in 40 elderly patients with major depressive disorder found saffron and sertraline produced equivalent results. Another trial in 66 patients with depression and anxiety found saffron’s calming effects were comparable to citalopram, with no severe side effects.
A critical caveat: these trials enrolled people with mild to moderate depression. There is no good evidence that saffron works for severe or treatment-resistant depression, and it should not be treated as a substitute for medication in those cases.
How Saffron Works in the Brain
Saffron contains two active compounds that appear to drive its antidepressant effects. These compounds block the reabsorption of serotonin, dopamine, and norepinephrine in the brain, which is the same basic mechanism used by most prescription antidepressants. By keeping more of these mood-regulating chemicals available between nerve cells, saffron can lift mood in a similar way to an SSRI.
Animal studies suggest saffron’s active compounds also increase levels of a protein that supports the growth and survival of brain cells, particularly in the hippocampus, a brain region involved in mood regulation. This protein tends to be lower in people with depression, and boosting it is one of the ways that exercise and several antidepressant drugs produce their effects.
Dosage and How Long It Takes to Work
Nearly every successful trial used 30 mg per day of saffron extract, typically split into two 15 mg doses. This is the dose with the strongest evidence behind it. Some trials used stigma (the red threads of the saffron flower), others used petal extract, and both showed antidepressant activity. The largest trial used a slightly lower dose of 28 mg daily of a standardized extract and still found significant benefits.
You won’t feel a difference overnight. In clinical trials, measurable improvements typically appeared after two to four weeks, with stronger effects building through week six. One trial tracking remission rates found that only 6.7% of participants had fully remitted by week two, but that number climbed to 63.3% by week six. Standard antidepressants often take 8 to 12 weeks for full remission, so saffron’s timeline is at least comparable and possibly slightly faster for mild to moderate symptoms.
Side Effects and Safety
At the standard 30 mg daily dose, saffron is well tolerated. Side effects reported in trials were mild and occurred at rates only slightly higher than placebo: occasional nausea, dry mouth, decreased appetite, headache, and anxiety. In some trials, the placebo group actually reported more side effects than the saffron group.
One notable advantage over prescription antidepressants is that saffron does not appear to cause significant sexual dysfunction, a common complaint with SSRIs. In one eight-week trial, sexual side effects were actually more frequent in the placebo group than in the saffron group.
Higher doses are a different story. A short-term study of 400 mg per day (more than 13 times the standard dose) caused drops in blood pressure and changes in kidney markers. Animal studies at very high doses showed liver and kidney damage. These doses are far beyond what any supplement provides, but the takeaway is clear: more is not better. Stick to 30 mg or less of a standardized extract.
What to Look for in a Supplement
Saffron quality varies enormously, and using a standardized extract matters. The trials showing benefits used extracts with verified levels of active compounds, not culinary saffron sprinkled on food. Cooking saffron contains these compounds too, but in unpredictable amounts that are almost certainly too low to produce antidepressant effects.
Look for supplements that specify the amount of saffron extract per capsule (ideally 15 mg for a twice-daily dose or 28 to 30 mg for a single daily dose) and that use standardized extracts with defined levels of active compounds. Third-party testing seals from organizations like USP or NSF add an extra layer of reliability, since the supplement industry is not tightly regulated and adulteration of saffron products is common.
Limitations of the Evidence
Despite the promising results, the saffron research has real weaknesses. Most trials enrolled only 40 to 66 participants, which increases the chance of inflated effect sizes. The majority were conducted by a small number of research groups in Iran, where saffron is culturally significant and commercially important. Larger, more geographically diverse trials are needed to confirm these findings.
The longest trials ran 12 weeks, so there is little data on what happens with extended use over months or years. Depression is often a chronic or recurring condition, and knowing whether saffron maintains its effects long-term is an important unanswered question. Because saffron influences serotonin in a way similar to SSRIs, there is also a theoretical risk of serotonin-related interactions if you combine it with prescription antidepressants, though this has not been formally studied.